Clinical Trial Update: Evolocumab Versus LDL Apheresis in Patients With Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing evolocumab to LDL apheresis in patients with hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Hospital General Universitario Gregorio Marañon | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED